123 related articles for article (PubMed ID: 38507993)
1. A new copper(II) complex containing long-chain aliphatic hydrazide and 1,10-phenanthroline upregulates ADP hydrolysis in triple-negative breast cancer cells.
Ferreira HSV; Ramos LMS; Silva FC; Alves DL; de Menezes Pereira G; de Oliveira Santiago PH; de Almeida AM; Ellena J; Corbi PP; Oliveira CG; de Almeida MV; Fürstenau CR; Borges DS; Siqueira RP; Guerra W; Araújo TG
J Inorg Biochem; 2024 Jun; 255():112524. PubMed ID: 38507993
[TBL] [Abstract][Full Text] [Related]
2. Novel copper(II) complexes with hydrazides and heterocyclic bases: Synthesis, structure and biological studies.
Paixão DA; Marzano IM; Jaimes EHL; Pivatto M; Campos DL; Pavan FR; Deflon VM; Maia PIDS; Da Costa Ferreira AM; Uehara IA; Silva MJB; Botelho FV; Pereira-Maia EC; Guilardi S; Guerra W
J Inorg Biochem; 2017 Jul; 172():138-146. PubMed ID: 28463762
[TBL] [Abstract][Full Text] [Related]
3. A selective Cu
Machado PHA; Paixão DA; Lino RC; de Souza TR; de Souza Bontempo NJ; Sousa LM; Van Petten de Vasconcelos Azevedo F; Orsolin PC; Lima PMAP; Martins IC; da Costa Guerra JF; Teixeira SC; Araújo TG; Goulart LR; Morelli S; Guerra W; de Oliveira Júnior RJ
Sci Rep; 2021 Dec; 11(1):24450. PubMed ID: 34961767
[TBL] [Abstract][Full Text] [Related]
4. Salicylate •Phenanthroline copper (II) complex induces apoptosis in triple-negative breast cancer cells.
Fan L; Tian M; Liu Y; Deng Y; Liao Z; Xu J
Oncotarget; 2017 May; 8(18):29823-29832. PubMed ID: 28415735
[TBL] [Abstract][Full Text] [Related]
5. Mixed ligand copper(II) complexes of N,N-bis(benzimidazol-2-ylmethyl)amine (BBA) with diimine co-ligands: efficient chemical nuclease and protease activities and cytotoxicity.
Loganathan R; Ramakrishnan S; Suresh E; Riyasdeen A; Akbarsha MA; Palaniandavar M
Inorg Chem; 2012 May; 51(10):5512-32. PubMed ID: 22559171
[TBL] [Abstract][Full Text] [Related]
6. Tetramethyl-phenanthroline copper complexes in the development of drugs to treat cancer: synthesis, characterization and cytotoxicity studies of a series of copper(II)-L-dipeptide-3,4,7,8-tetramethyl-phenanthroline complexes.
Alvarez N; Leite CM; Napoleone A; Mendes LFS; Fernández CY; Ribeiro RR; Ellena J; Batista AA; Costa-Filho AJ; Facchin G
J Biol Inorg Chem; 2022 Aug; 27(4-5):431-441. PubMed ID: 35524804
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, structural characterization and cytotoxic activity of ternary copper(II)-dipeptide-phenanthroline complexes. A step towards the development of new copper compounds for the treatment of cancer.
Iglesias S; Alvarez N; Torre MH; Kremer E; Ellena J; Ribeiro RR; Barroso RP; Costa-Filho AJ; Kramer MG; Facchin G
J Inorg Biochem; 2014 Oct; 139():117-23. PubMed ID: 25033418
[TBL] [Abstract][Full Text] [Related]
8. Interaction with CT-DNA and in vitro cytotoxicity of two new copper(II)-based potential drugs derived from octanoic hydrazide ligands.
Chowdhury M; Biswas N; Saha S; Rahaman A; Gupta PS; Banerjee A; Mandal DP; Bhattacharjee S; Zangrando E; Sciortino G; Pisanu F; Garribba E; Roy Choudhury R; Roy Choudhury C
J Inorg Biochem; 2024 Jul; 256():112546. PubMed ID: 38593611
[TBL] [Abstract][Full Text] [Related]
9. Fluorescent mixed ligand copper(II) complexes of anthracene-appended Schiff bases: studies on DNA binding, nuclease activity and cytotoxicity.
Jaividhya P; Ganeshpandian M; Dhivya R; Akbarsha MA; Palaniandavar M
Dalton Trans; 2015 Jul; 44(26):11997-2010. PubMed ID: 26076117
[TBL] [Abstract][Full Text] [Related]
10. Copper(II) Complexes of Phenanthroline and Histidine Containing Ligands: Synthesis, Characterization and Evaluation of their DNA Cleavage and Cytotoxic Activity.
Leite SM; Lima LM; Gama S; Mendes F; Orio M; Bento I; Paulo A; Delgado R; Iranzo O
Inorg Chem; 2016 Nov; 55(22):11801-11814. PubMed ID: 27934321
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, X-ray crystal structures and biomimetic and anticancer activities of novel copper(II)benzoate complexes incorporating 2-(4'-thiazolyl)benzimidazole (thiabendazole), 2-(2-pyridyl)benzimidazole and 1,10-phenanthroline as chelating nitrogen donor ligands.
Devereux M; O Shea D; Kellett A; McCann M; Walsh M; Egan D; Deegan C; Kedziora K; Rosair G; Müller-Bunz H
J Inorg Biochem; 2007 Jun; 101(6):881-92. PubMed ID: 17397929
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and structural characterization of a series of ternary copper(II)-L-dipeptide-neocuproine complexes. Study of their cytotoxicity against cancer cells including MDA-MB-231, triple negative breast cancer cells.
Alvarez N; Viña D; Leite CM; Mendes LFS; Batista AA; Ellena J; Costa-Filho AJ; Facchin G
J Inorg Biochem; 2020 Feb; 203():110930. PubMed ID: 31812025
[TBL] [Abstract][Full Text] [Related]
13. Mixed ligand complexes of Co(II), Ni(II) and Cu(II) with quercetin and diimine ligands: synthesis, characterization, anti-cancer and anti-oxidant activity.
Mutlu Gençkal H; Erkisa M; Alper P; Sahin S; Ulukaya E; Ari F
J Biol Inorg Chem; 2020 Feb; 25(1):161-177. PubMed ID: 31832781
[TBL] [Abstract][Full Text] [Related]
14. Cu(II) complexes with co-planar [Cu(II)(N-N)(HIMC⁻)], their anti-cancer activities, ΔG, ΔE and solid luminescence.
Cheng YF; Lu XM; Wang G
Dalton Trans; 2014 Apr; 43(14):5357-63. PubMed ID: 24519174
[TBL] [Abstract][Full Text] [Related]
15. Novel copper(II) complexes as new promising antitumour agents. A crystal structure of [Cu(1,10-phenanthroline-5,6-dione)2(OH2)(OClO3)](ClO4).
Pivetta T; Trudu F; Valletta E; Isaia F; Castellano C; Demartin F; Tuveri R; Vascellari S; Pani A
J Inorg Biochem; 2014 Dec; 141():103-113. PubMed ID: 25238635
[TBL] [Abstract][Full Text] [Related]
16. Selective anticancer copper(II)-mixed ligand complexes: targeting of ROS and proteasomes.
Ng CH; Kong SM; Tiong YL; Maah MJ; Sukram N; Ahmad M; Khoo AS
Metallomics; 2014 Apr; 6(4):892-906. PubMed ID: 24549332
[TBL] [Abstract][Full Text] [Related]
17. Preparation, cytotoxic activity and DNA interaction studies of new platinum(II) complexes with 1,10-phenanthroline and 5-alkyl-1,3,4-oxadiazol-2(3H)-thione derivatives.
Souza WA; Ramos LMS; de Almeida AM; Tezuka DY; Lopes CD; Moreira MB; Zanetti RD; Netto AVG; Ferreira FB; de Oliveira RJ; Guedes GP; de Albuquerque S; Silva JRL; Pereira-Maia EC; Resende JALC; de Almeida MV; Guerra W
J Inorg Biochem; 2022 Dec; 237():111993. PubMed ID: 36108344
[TBL] [Abstract][Full Text] [Related]
18. Magnetic property, DFT calculation, and biological activity of bis[(μ(2)-chloro)chloro(1,10-phenanthroline)copper(II)] complex.
Mroueh M; Daher C; Hariri E; Demirdjian S; Isber S; Choi ES; Mirtamizdoust B; Hammud HH
Chem Biol Interact; 2015 Apr; 231():53-60. PubMed ID: 25753321
[TBL] [Abstract][Full Text] [Related]
19. New binary copper(II) complexes containing intercalating ligands: DNA interactions, an unusual static quenching mechanism of BSA and cytotoxic activities.
İnci D; Aydın R; Vatan Ö; Zorlu Y; Çinkılıç N
J Biomol Struct Dyn; 2018 Nov; 36(15):3878-3901. PubMed ID: 29132253
[TBL] [Abstract][Full Text] [Related]
20. Efficient hydrolytic cleavage of DNA and antiproliferative effect on human cancer cells by two dinuclear Cu(II) complexes containing a carbohydrazone ligand and 1,10-phenanthroline as a coligand.
Parsekar SU; Singh M; Mishra DP; Antharjanam PKS; Koley AP; Kumar M
J Biol Inorg Chem; 2019 May; 24(3):343-363. PubMed ID: 30887122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
